Phase 1 Sjogren's Syndrome trials recruiting now
All Sjogren's Syndrome trials, every phase
7
Phase 1 recruiting
Other phases for Sjogren's Syndrome
Phase 1 Sjogren's Syndrome trials
- A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
- Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.